During the past decade, Eurecat conducted 7 clinical trials. In the 10-year time frame, 7 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 7 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Eurecat" #1 collaborator was "ADM-BIOPOLIS S.L." with 1 trials as a collaborator, "Catholic University of Murcia (UCAM)" with 1 trials as a collaborator, "Circe, S.L." with 1 trials as a collaborator, "Grandes Vinos y Viñedos S.A." with 1 trials as a collaborator and "Hospital Universitari Sant Joan de Reus" with 1 trials as a collaborator. Other collaborators include 1 different institutions and companies that were collaborators in the rest 11 trials.

According to Clinical.Site data, the most researched conditions in "Eurecat" are "Biological Availability" (2 trials), "Allergic Rhinitis" (1 trials), "Aluminium Overload" (1 trials), "Cardiovascular Diseases" (1 trials) and "Cardiovascular Risk Factor" (1 trials). Many other conditions were trialed in "Eurecat" in a lesser frequency.

Most popular intervention types in "Eurecat" are "Dietary Supplement" (4 trials), "Other" (2 trials) and "Device" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (2 trials), "Control group" (1 trials), "Diet and behavioural intervention" (1 trials), "ES1 group" (1 trials) and "Extract from the wine industry" (1 trials). Other intervention names were less common.

The vast majority of trials in "Eurecat" are 6 trials for "All" genders and 1 trials for "Female" genders.

Currently, there are NaN active trials in "Eurecat". undefined are not yet recruiting, 2 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 5 completed trials in Eurecat, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Eurecat, 0 "Phase 1" clinical trials were conducted, 0 "Phase 2" clinical trials and 0 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 6 trials that are defined as “Not Applicable".